About Kreatech
Kreatech is a company based in Amsterdam (Netherlands) founded in 1996 was acquired by Leica Biosystems in July 2013. Kreatech has raised $3.02 million across 1 funding round from investors including Life Sciences Partners, Alafi Capital and Leica Biosystems. Kreatech operates in a competitive market with competitors including Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
- Headquarter Amsterdam, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.02 M (USD)
in 1 rounds
-
Latest Funding Round
$3.02 M (USD), Series A
Nov 27, 2009
-
Investors
Life Sciences Partners
& 2 more
-
Employee Count
Not available
-
Acquired by
Leica Biosystems
(Jul 08, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Kreatech
Kreatech has successfully raised a total of $3.02M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.02 million completed in November 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kreatech
Kreatech has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Life Sciences Partners, Alafi Capital and Leica Biosystems.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life-Sciences focused early & growth stage VC firm investing in the US & Europe
|
Locked | Locked | Locked | |
|
Private equity investments in life sciences businesses are managed.
|
Locked | Locked | Locked | |
|
Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide.
|
Locked | Locked | Locked |
Investor details for Kreatech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kreatech
Investment portfolio details for Kreatech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kreatech
Detailed financials for Kreatech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kreatech Comparisons
Peer comparison for Kreatech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kreatech
Kreatech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Developer of nucleic acid detection and quantification systems
|
|
| Locked | Locked | Locked |
Electrophoresis-based in vitro diagnostics products are developed and provided.
|
Detailed competitors of Kreatech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kreatech
Complete news archive for Kreatech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kreatech
Kreatech was founded in 1996 and raised its 1st funding round 13 years after it was founded.
Kreatech is headquartered in Amsterdam, Netherlands.
Kreatech is a funded company, having raised a total of $3.02M across 1 funding round to date.
Kreatech was founded in 1996 in Amsterdam, Netherlands, within the biotechnology sector. FISH probes are developed for detecting and quantifying genetic aberrations linked to cancer and other diseases. A portfolio of REPEAT-FREE DNA-FISH probes is offered, along with microarray labeling solutions based on the proprietary Universal Linkage System technology. Operations focus on enabling diagnostic applications in research and clinical settings.
Kreatech's top competitors include Neogen, Qiagen and Parse Biosciences.
Kreatech has 3 investors. Key investors include Life Sciences Partners, Alafi Capital, and Leica Biosystems.